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Abstract 
 
A PROSPECTIVE STUDY OF MEDITERRANEAN DIET AND COGNITIVE DECLINE 
 
Ashley Childers  
B.S., Appalachian State University 
 
 
 
Chairperson:  Martin Root, PhD 
 
 
 Cognitive impairment, which affects 16-25% of older adults in the US and Canada, 
can have profound effects on health and quality of life.  Adherence to a Mediterranean Diet 
has been associated with better cognitive function and lower incidence of cognitive 
impairment in some studies, but results have been inconsistent.  The present study aims to 
analyze the relationship between Mediterranean Diet adherence and rates of cognitive 
decline. 
Data for this research were taken from the Atherosclerosis Risk in Communities 
(ARIC) study and includes 10,104 adults age 45-64 at baseline from 4 counties in the United 
States.  Food frequency questionnaire data were used to assess Mediterranean Diet adherence 
according to the Mediterranean-Style Dietary Pattern Score.  Cognitive function was assessed 
by combining the Delayed Word Recall, the Digit Symbol Substitution, and the Word 
Fluency tests administered at baseline and six-year follow-up.  Linear regression analysis, 
controlling for important covariates, was used to assess the association between 
Mediterranean Diet score and change in cognitive function over six years. 
 v 
The average Mediterranean Diet score at baseline was 20.0 ± 6.5 with average sub-
scores for whole grain and wine consumption at 1.2 ± 1.1 and 0.4 ± 1.1, respectively, out of a 
possible score of 10.  There was no significant relationship between Mediterranean Diet 
Score and cognitive change in univariate, demographic, or fully adjusted models. 
ARIC participants had low Mediterranean Diet adherence, particularly in whole grain 
and wine consumption.  Mediterranean Diet adherence had no significant relation with rates 
of cognitive change among ARIC participants.  
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Foreword 
 
 
 Chapter 2 of this thesis will be submitted to Nutrition and Healthy Aging, a peer-
reviewed journal published by IOS Press; it has been formatted according to the style guide 
for that journal.
 1 
Chapter One 
 Declines in cognition, defined as the ability to think, reason, and remember and 
encompassing language, attention, judgement and the ability to learn new things, are 
associated with increasing age and can have profound effects on health and quality of life.[1, 
2] As of 2007, an estimated 16-25% of people aged 65 and over in the United States and 
Canada were affected by cognitive impairment.[1]  Additionally, cognitive impairment 
increases the risk for more severe dementia, with an average of 32-38% of those diagnosed 
with mild cognitive impairment progressing to a diagnosis of Alzheimer’s disease (AD) – the 
sixth leading cause of death in the US and the fifth leading cause of death among people aged 
65 and over.[3]  As this segment of the population grows, the impact of cognitive impairment 
and AD is also expected to increase – it is projected that the number of older adults with AD 
will reach 7.1 million by 2025, a 35% increase over the current 5.3 million.[3] 
 The relationship between diet and cognitive impairment is complex, with dietary 
factors affecting both disease risk and progression and being affected by loss of function 
during the late stages of the disease.[4]  In their meta-analysis of plasma markers of nutrient 
status among people with AD, Lopes da Silva et al. found that those with AD had 
significantly lower plasma levels of folate and vitamins A, B12, C, and E (p < 0.001) than 
those without AD and that these lowered levels occurred independently of the protein-energy 
malnutrition common during the advanced stages of the disease.[5]   Dietary factors may also 
play a role in preventing the occurrence and slowing the progression of cognitive decline.  
Shakersain et al. used factor analysis to derive two dietary patterns among participants of the 
longitudinal Swedish National Study on Aging and Care – Kungsholmen (SNAC-K).  They 
found that high adherence to a Western dietary pattern, characterized by higher intakes of red 
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and processed meats, saturated and trans fats, refined grains, sugar, beer, and spirits, was 
associated with higher cognitive declines as measured by the Mini-Mental State Examination 
(MMSE) (β = -0.156, p < 0.001), while higher adherence to a “prudent” dietary pattern, 
characterized by higher intakes of fruits, vegetables, cooking oil, cereals, legumes, whole 
grains, rice, pasta, fish, low-fat dairy products, poultry, and water, was associated with less 
cognitive decline (β = 0.106, p = 0.011).[6]  In a randomized controlled trial of 233 older 
adults with mild cognitive impairment, de Jager et al. found that participants who received 
supplemental folate, vitamin B12 and vitamin B6, performed significantly better on the CLOX 
test of executive function at the 24-month follow-up than participants receiving placebo (p = 
0.015) when controlling for age, sex, education level and CLOX scores at baseline.[7]  In 
contrast, Haring et al. found no association between dietary patterns and risk of mild 
cognitive impairment (MCI) or probable dementia (PD) among participants in the Women’s 
Health Initiative Memory Study.  A sample of 6,425 postmenopausal women were assessed 
for incidence of MCI and PD over a median follow-up period of 9.11 years.  No significant 
relationship was found between relative risk of MCI and PD across quintiles of alternate 
Mediterranean Diet, Healthy Eating Index-2010, Alternate Healthy Eating Index-2010, and 
Dietary Approaches to Stop Hypertension scores (P values for trend = 0.30, 0.44, 0.23, and 
0.45, respectively)[8]. 
 The Mediterranean diet (MedDiet) is a dietary pattern consistent with the traditional 
foods of people living in countries bordering the Mediterranean Sea.  It is characterized by 
high intakes of fruits, vegetables, legumes, and whole grains, moderate intakes of fish and 
red wine, and use of olive oil as the primary source of fat.[9]  The protective effects of the 
MedDiet on cardiovascular disease risk and endpoints has been well-established and 
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adherence has also been associated with reduced all-cause mortality, incidence of and 
mortality due to cancer, and incidence of neurodegenerative diseases.[9, 10] 
 There has been conflicting evidence of the effect of the MedDiet on cognitive decline.  
Ye et al. found that better adherence to the MedDiet was associated with better global 
cognitive function as measured by the MMSE among middle-aged and older adults in a 
cross-sectional analysis of participants in the Boston Puerto Rican Health Study.  Each one-
point increase in adherence to the MedDiet (scores ranged from 0 to 9) was associated with a 
0.14-point increase in MMSE score (β = 0.14, p = 0.012).  Furthermore, participants in the 
highest quintile of MedDiet adherence were 50% less likely to have cognitive impairment, 
which was defined as MMSE scores < 21 for those with less than a high school education, < 
23 for those who had completed high school, and < 24 for those with some college education 
or higher (OR = 0.51; 95% CI 0.33 to 0.79).[11]  Similarly, Bhushan et al. examined the 
relationship between MedDiet adherence and subjective cognitive function (SCF), self-
assessed change in cognition measured by questions such as “Do you have more trouble than 
usual remembering recent events?” and “Do you have more trouble than usual following a 
group conversation or a plot in a TV program due to your memory?”[12]  SCF has been 
found to correlate with the presence of biomarkers of AD and is a strong predictor of future 
dementia[13, 14].  Results showed that men in the highest quintile of MedDiet adherence 
were 36% less likely to have a poor SCF score (defined as affirmative answers on 3 or more 
items of the 6-item SCF questionnaire) (OR = 0.64; 95% CI 0.55 to 0.75, p < 0.001) and 24% 
less likely to have a moderate SCF score (defined as affirmative answers on 1-2 items of the 
6-item SCF questionnaire) (OR = 0.76; 95% CI 0.70 to 0.83; p < 0.001) than those in the 
lowest quintile of MedDiet adherence.[12]  In their analysis of 1,410 participants from the 
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Three-City prospective cohort study of older adults in France, Feárt et al. found that higher 
adherence to the MedDiet was associated with slower cognitive decline as measured by the 
MMSE over a seven year follow-up period (β = -0.006; 95% CI -0.01 to -0.0003; p = 
.04).[15]   In a subset of the PREDIMED randomized controlled trial of the MedDiet among 
people at high risk for cardiovascular disease, Martínez-Lapiscina et al. found that 
participants following the MedDiet supplemented with extra-virgin olive oil had significantly 
higher scores on the MMSE and the Clock Drawing Test (CDT) than those following the 
low-fat control diet (adjusted differences: 0.62; 95% CI 0.18 to 1.05, p = 0.005 and 0.51; 
95% CI 0.20 to 0.82, p = 0.001 for MMSE and CDT, respectively).[16]  A follow-up sub-
study of the PREDIMED trial measured the rates of cognitive decline over a median follow-
up period of 4.1 years among a group of 447 older adults at high cardiovascular risk.  
Participants were randomized to intervention with MedDiet supplemented with extra-virgin 
olive oil, MedDiet supplemented with nuts, or a low-fat control diet.  Valls-Pedret et al. 
found that participants in the MedDiet plus nuts group had significantly less decline in 
memory, as measured by a composite score consisting of the mean standardized individual 
change scores of the Rey Auditory Verbal Learning Test (RAVLT) and the Verbal Paired 
Associates test from the Wechsler Memory Scale with a mean change of 0.09 (95% CI -0.05 
to 0.23) compared with a mean change of -0.17 (95% CI -0.32 to -0.01) in the control group 
(p = 0.04).  Additionally, the MedDiet plus extra-virgin olive oil group had significantly less 
decline in global cognition, determined using the mean standardized changes for all 
neuropsychological tests (including the above mentioned as well as the Digit Scale subtest of 
the Wechsler Adult Intelligence Scale, parts one and two of the Color Trail Test, and the 
 5 
MMSE) with a mean change of 0.05 (95% CI -0.11 to 0.21) compared with -0.38 (95% CI -
0.57 to -0.18) in the control group (p = 0.005).[17] 
 One possible reason for the association between MedDiet and better cognitive 
outcomes is the effect of MedDiet on brain volumes and cortical thickness, measures that 
have been associated with cognitive decline.[18]  In their cross-sectional study of 674 older 
adults (aged 65 or greater) from the Washington Heights/Hamilton Heights Inwood 
Columbia Aging Project (WHICAP), Gu et al. found that higher MedDiet adherence was 
associated with larger total brain volumes, total gray matter volumes, and total white matter 
volumes, as measured by MRI.  Compared to those with high MedDiet adherence, 
participants with low MedDiet adherence had brain atrophy similar to that found after five 
years of aging.  Secondary analysis found that higher fish intake and lower meat intake were 
the two MedDiet components significantly associated with larger brain volumes.[19]  These 
findings support the hypothesis that the increased polyunsaturated fatty acid (PUFA) content 
of the MedDiet may play a role in preserving cognitive function by slowing the degeneration 
of cholinergic basal forebrain neurons which has been shown to play a role in age-related 
cognitive decline and AD.[20]  The high antioxidant content of the MedDiet may also play a 
role in its potential neuroprotective effect through several mechanisms including preventing 
oxidative damage to existing neurons and the neurogenerative process, inhibiting cytokine 
production in microglia cells, and improving cerebral blood flow.[20] 
 While many studies have shown an association between MedDiet and cognitive 
outcomes, results have been inconsistent.  Vercambre et al. found no significant differences 
in the rate of cognitive decline, as measured by a battery of five validated tests administered 
at baseline and an average of 5.4 years later, across tertiles of MedDiet adherence among a 
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subsample of participants in the Women’s Antioxidant Cardiovascular Study.  These results 
held true in secondary analyses using an alternate MedDiet scoring method.[21]   Similarly, 
in their analysis of middle-aged participants (60 to 64 years old at baseline) in the PATH 
Through Life Study in Canberra, Australia, Cherbuin and Anstey found that higher adherence 
to the MedDiet did not have a protective effect against the development of cognitive 
impairment over a four-year follow-up period.[22]  In their analysis of a subset of 
participants aged 65 and older from the Women’s Health Study, Samieri et al. also found no 
significant relationship between MedDiet adherence and mean global cognition and verbal 
memory scores over a four-year follow-up period.  The fact that no association was found 
despite a large sample size of 6,174 participants, a test battery with high validity and 
reliability (including the Telephone Interview for Cognitive Status, immediate and delayed 
recalls of the East Boston Memory Test, and delayed recall of the Telephone Interview for 
Cognitive Status 10-word list), and a low loss to follow-up (82% of participants completed 
all three cognitive assessments over time), raises important questions about MedDiet and 
cognitive outcomes.[23] 
 These conflicting results, coupled with the current lack of effective treatments for 
cognitive impairment and AD, indicate a need for further research into possible preventative 
measures.[4]  The aim of the present study is to analyze the association between adherence to 
the MedDiet and cognitive outcomes among participants of the Atherosclerosis Risk in 
Communities (ARIC) study.  Based on the above mentioned results from similar studies, it is 
hypothesized that better adherence to the MedDiet will be associated with decreased rates of 
cognitive decline over time. 
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Chapter Two 
Abstract 
BACKGROUND:  Cognitive impairment affects 16-25% of older adults in the US and 
Canada and has profound effects on quality of life.  Adherence to a Mediterranean Diet 
(MedDiet) has been associated with better cognitive function in some studies, but results 
have been inconsistent.   
OBJECTIVE:  To analyze the relationship between MedDiet adherence and rates of 
cognitive decline. 
METHODS:  Data were taken from the ARIC study, which included 10,104 adults age 45-64 
from 4 counties in the US.  Food frequency questionnaire data was used to assess MedDiet 
adherence according to the Mediterranean-Style Dietary Pattern Score.  Cognitive function 
was assessed by combining Delayed Word Recall, Digit Symbol Substitution, and Word 
Fluency tests administered at baseline and six-year follow-up.  Linear regression was used to 
assess the association between MedDiet score and change in cognitive function. 
RESULTS:  The average MedDiet score was 20.0 ± 6.5 with sub-scores for whole grain and 
wine consumption at 1.2 ± 1.1 and 0.4 ± 1.1, respectively.  There was no significant 
relationship between MedDiet Score and cognitive change in univariate, demographic, or 
fully adjusted models. 
CONCLUSIONS:  ARIC participants had low MedDiet adherence, particularly in whole 
grain and wine consumption.  MedDiet adherence was not significantly associated with 
cognitive change among ARIC participants.  
Keywords:  diet; diet, Mediterranean; cognition; cognitive dysfunction 
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Introduction 
Declines in cognition, defined as the ability to think, reason, and remember and 
encompassing language, attention, judgement and the ability to learn new things, are 
associated with increasing age and can have profound effects on health and quality of life.[1, 
2]   As of 2007, an estimated 16-25% of people aged 65 and over in the United States and 
Canada were affected by cognitive impairment.[1]  Additionally, cognitive impairment 
increases the risk for more severe dementia, with an average of 32-38% of those diagnosed 
with mild cognitive impairment progressing to a diagnosis of Alzheimer’s disease – the sixth 
leading cause of death in the US and the fifth leading cause of death among people aged 65 
and over.[3]  As this segment of the population grows, the impact of cognitive impairment 
and AD is also expected to increase – it is projected that the number of older adults with AD 
will reach 7.1 million by 2025, a 35% increase over the current 5.3 million.[3] 
 The relationship between diet and cognitive impairment is complex, with dietary 
factors affecting both disease risk and progression and being affected by loss of function 
during the late stages of the disease.[4, 5] Dietary factors may also play a role in preventing 
the occurrence and slowing the progression of cognitive decline.  Shakersain et al. found that 
high adherence to a Western dietary pattern, characterized by higher intakes of red and 
processed meats, saturated and trans fats, refined grains, sugar, beer, and spirits, was 
associated with higher cognitive declines as measured by the Mini-Mental State Examination 
(MMSE) (β = -0.156, p < 0.001).  In contrast, higher adherence to a “prudent” dietary 
pattern, characterized by higher intakes of fruits, vegetables, cooking oil, cereals, legumes, 
whole grains, rice, pasta, fish, low-fat dairy products, poultry, and water, was associated with 
less cognitive decline (β = 0.106, p = 0.011).[6]   
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 The Mediterranean diet (MedDiet) is a dietary pattern consistent with the traditional 
foods of people living in countries bordering the Mediterranean Sea.  It is characterized by 
high intakes of fruits, vegetables, legumes, and whole grains, moderate intakes of fish and 
red wine, and use of olive oil as the primary source of fat.[9]  The protective effects of the 
MedDiet on cardiovascular disease risk and endpoints has been well-established and 
adherence has also been associated with reduced all-cause mortality, incidence of and 
mortality due to cancer, and incidence of neurodegenerative diseases.[9, 10] 
 Previous studies of the relationship between the MedDiet and cognitive decline have 
yielded mixed results.  In their analysis of middle-aged participants in the PATH Through 
Life Study in Canberra, Australia, Cherbuin and Anstey found that higher adherence to the 
MedDiet did not have a protective effect against the development of cognitive impairment 
over a four-year follow-up period.[22]   Similarly, Vercambre et al. found no significant 
differences in the rate of cognitive decline, as measured by a battery of five validated tests 
administered at baseline and an average of 5.4 years later, across tertiles of MedDiet 
adherence among a subsample of participants in the Women’s Antioxidant Cardiovascular 
Study.  These results held true in secondary analyses using an alternate MedDiet scoring 
method.[21]  
 In contrast, Ye et al. found that better adherence to the MedDiet was associated with 
better global cognitive function as measured by the MMSE among middle-aged and older 
adults in the Boston Puerto Rican Health Study.  Each one-point increase in adherence to the 
MedDiet was associated with a 0.14-point increase in MMSE score (β = 0.14, p = 0.012).  
Furthermore, participants in the highest quintile of MedDiet adherence were 50% less likely 
to have cognitive impairment than those in the lowest quintile (OR = 0.51; 95% CI 0.33 to 
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0.79).[11]  In a subset of the PREDIMED randomized controlled trial of the MedDiet among 
people at high risk for cardiovascular disease, Martínez-Lapiscina et al. found that 
participants following the MedDiet supplemented with extra-virgin olive oil had significantly 
higher scores on the MMSE and the Clock Drawing Test (CDT) than those following the 
low-fat control diet (adjusted differences: 0.62; 95% CI 0.18 to 1.05, p = 0.005 and 0.51; 
95% CI 0.20 to 0.82, p = 0.001 for MMSE and CDT, respectively).[16]  A follow-up sub-
study by Valls-Pedret et al. found that participants following the MedDiet supplemented with 
nuts had significantly less decline in memory over a median follow-up period of 4.1 years 
than those in the control group (p = 0.04) while participants following the MedDiet 
supplemented with olive oil had significantly less decline in global cognition than those in 
the control group (p = 0.005).[17] 
 These conflicting results, coupled with the current lack of effective treatments for 
cognitive impairment and AD, indicate a need for further research into possible preventative 
measures.[4]  The aim of the present study is to analyze the association between adherence to 
the MedDiet and cognitive outcomes among participants of the Atherosclerosis Risk in 
Communities (ARIC) study.  It is hypothesized that better adherence to the MedDiet will be 
associated with decreased rates of cognitive decline over time. 
Materials and Methods 
Study Population 
 The ARIC study, sponsored by the National Heart, Lung, and Blood Institute, is a 
large prospective cohort study designed to examine the risk factors for and clinical outcomes 
of atherosclerosis.  Participants were recruited from four communities in the US: Forsyth 
County, NC, the city of Jackson, MS, the northwestern suburbs of Minneapolis, MN, and 
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Washington County, MD.  The cohort recruited from Jackson, MS includes only African 
Americans, while cohorts from the other three communities include both African American 
and White participants.  Probability sampling was used to recruit approximately 4,000 
participants between the ages of 35 and 74 from each community for a total of 14,590 
participants.  Baseline examinations were performed between 1987 and 1989 and follow-up 
examinations occurred at three-year intervals (between 1990 and 1992 for visit 2, 1993 to 
1995 for visit 3, and 1996 to 1998 for visit 4)[24, 25] 
Dietary Intake and Mediterranean Diet Score 
 Dietary intake was measured using a 66-item food frequency questionnaire (FFQ), 
modified from the validated Willett FFQ, administered by trained interviewers at baseline 
and visit 3.[26, 27] Caloric intake was derived from FFQ data using the Willett nutrient 
database.[28] Dietary data were evaluated for adherence to the MedDiet using the 
Mediterranean-Style Dietary Pattern Score (MSDPS) developed by Rumawas et al. for use in 
a non-Mediterranean population.  Participants’ consumption of whole grains, fruits, 
vegetables, dairy, wine, fish, poultry, olives, legumes, nuts, potatoes and other starchy root 
vegetables, eggs, sweets, and meat were evaluated against the recommended intakes from the 
Mediterranean diet pyramid.  Participants consuming the recommended number of servings 
received the highest score, with scores incrementally lowered for under- and 
overconsumption.  The MSDPS also factors in the proportion of total energy intake from 
MedDiet foods to account for the high consumption of foods outside of the Mediterranean 
diet pyramid expected in cohorts from the United States (see Figure 1).  While there is no 
gold standard by which MedDiet scores can be validated, the MSDPS was tested for validity 
in the Framingham Offspring Cohort and found to correlate well with intakes of nutrients 
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associated with the MedDiet.[29]  The average MSDPS score from baseline and visit 3 was 
used in analysis.  One significant limitation of the application of the MSDPS to the ARIC 
cohort involved the assessment of participants’ use of olive oil.  Use of olive oil as the 
primary cooking oil is one component of the MSDPS, with those using only olive oil 
receiving the maximum score of 10, those using olive oil and other oils receiving a score of 
5, and those using no olive oil receiving a score of zero.  The FFQ used in the ARIC study 
did not assess the use of olive oil, so all participants were assigned a score of zero for this 
component. 
Cognition 
 Cognitive function was assessed using the Delayed Word Recall (DWR) test, the 
Digit Symbol Substitution (DSS) test from the Wechsler Adult Intelligence Scale, and the 
Word Fluency (WF) test from the Multilingual Aphasia Examination.  The DWR evaluates 
short term memory by requiring participants to recall a series of 10 words after a five minute 
interval during which another test is administered.  After the five minute interval, participants 
are asked to compose sentences using the 10 words and are given a score from 0 to 10 based 
on the number of words recalled.  The DSS is a timed test of psychomotor ability during 
which participants are asked to translate a series of numbers into symbols using a key.  
Scores are assigned based on the number of translations made during a 90 second interval, 
with a maximum possible score of 93.  The WF is used as an indicator of linguistic 
impairment and early cognitive decline.  Participants are given a letter of the alphabet and 
asked to list as many words beginning with that letter as possible during a 60 second time 
frame.  ARIC participants were asked to perform the test three times, using the letters F, A, 
and S.  Scores were assigned based on the total number of words over the three tests.  The 
 13 
test battery was administered by trained interviewers during the second and fourth 
examinations.[30, 31] For the present study, scores for each test were standardized by taking 
the difference of baseline scores from 6-year follow-up scores and dividing by the standard 
deviation of the difference.  A total score for change in cognitive function was obtained by 
summing the three standardized test change scores for each participant. 
Demographic and Other Confounding Variables 
 Demographic information, including age, race/ethnicity, sex, and education level, was 
collected by trained interviewers at baseline.  Self-reported smoking status was classified as 
current smoker or non-smoker.[26] Blood pressure was measured three times while 
participants were seated and after five minutes of rest.  The average of the second and third 
measurements was recorded.  Hypertension was defined as systolic blood pressure ≥ 140 
mmHg or diastolic blood pressure ≥ 90 mmHg, or use of antihypertensive medication.[32] 
Diabetes was defined as fasting plasma glucose ≥ 126 mg/dL, self-reported physician 
diagnosis, or use of glucose-lowering medications.  Body mass index was calculated as 
kg/m
2
.  Physical activity level was assessed using the sum of work, leisure, and sports 
activity scores.[26]  
Statistics 
Statistical analysis was performed using IBM SPSS Statistics, version 24 (IBM Corp., 
Armonk, NY).  Linear regression models of change in cognitive function versus MedDiet 
score were created, controlling for age, race/ethnicity, sex, education level, smoking status, 
physical activity, BMI, and presence of hypertension and diabetes.   
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Results 
 A total of 14,950 participants were assessed for inclusion in the present study.  Of 
those, 5,036 participants were excluded due to missing FFQ, cognitive function, or covariant 
data.  A further 48 participants were excluded due to very high or very low cognitive 
difference scores for a total sample size of 10,104 (see Figure 1).  The majority of study 
participants were white (n = 823,476) and female (n = 559,762).  Ages at baseline ranged 
from 44 to 66 years with a mean age of 54.0  5.7.  Participants were overweight on average, 
with MedDiet scores that ranged from 1.2 to 47.0.  Total cognitive change scores from 
baseline to visit four ranged from -12.3 to 12.9, with participants declining by 0.6 points, on 
average.  Characteristics of the study sample are presented in Table 1. 
 MedDiet adherence was low overall, with particularly low adherence in the wine and 
whole grain categories, with average scores of 0.4  1.1 and 1.2  1.1 respectively.  Highest 
adherence was seen in the fruit category, with an average score of 5.3  2.4 (see Table 2).  
Participants in the ARIC cohort consumed, on average, only 1.0 0.9 servings per day of 
whole grains out of the 8 servings per day recommended on the traditional MedDiet pyramid. 
The ARIC cohort had similar low intakes of wine (0.08  0.27 servings per day out of the 
recommended 3 servings for men and 1.5 servings for women), vegetables (1.5  1.0 
servings per day out of the recommended 6), and fish (2.1  2.1 servings per week out of the 
recommended 6).  ARIC participants also consumed greater than three times the 
recommended amounts of sweets (9.6  8.6 servings per week of the recommended 3) and 
meats (3.2  2.5 servings per week of the recommended 1).[33] 
Linear regression comparing MedDiet scores and change in cognitive scores revealed 
no significant association.  This was maintained when controlling for demographic variables 
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(age, sex, and ethnicity) and important covariates (education level, smoking status, physical 
activity level, BMI, presence of hypertension, and presence of diabetes) (see Table 3).  
Subsequent analyses of subgroups revealed no significant differences in MedDiet score 
between males and females or between participants from the four examination centers.  No 
significant association between MedDiet scores and cognitive change was found in any of 
these subgroups. 
Discussion 
In this large sample of middle aged adults, there was no significant association 
between adherence to a Mediterranean Style diet pattern and preserved cognitive function.  
These results are inconsistent with much of the literature on Mediterranean Diet and 
cognitive decline.  It is possible that the low MedDiet adherence in this sample contributed to 
the null results.  Out of a possible score of 100, the average MSDPS in this cohort was 20.0  
6.5.  In contrast, the average MedDiet score among participants in the Boston Puerto Rican 
Health Study, in which Ye et al. found that better adherence to the MedDiet was associated 
with better global cognitive function as measured by the MMSE among middle-aged and 
older adults, was 4.37  1.61 out of a maximum possible score of 9.[11]  Similarly, Féart et 
al. reported a mean MedDiet score of 4.36  1.66 out of a maximum possible score of 9 in 
their study of 1,410 participants from the Three-City prospective cohort study of older adults 
in France, in which they found that higher adherence to the MedDiet was associated with 
slower cognitive decline as measured by the MMSE over a seven year follow-up period.[15] 
Compared with the recommended intakes from the MedDiet pyramid, the ARIC 
cohort had very low intake of whole grains, wine, vegetables and fish.  While Samieri et al. 
found a similar lack of association between MedDiet and mean global cognition scores in 
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their analysis of women aged 65 and over from the Women’s Health Study, they also noted a 
modest association between higher intakes of whole grains and better cognitive scores.[23]  
Whole grains are rich in B-vitamins, higher intakes of which have been associated with less 
cognitive decline, possibly through their role in lowering plasma levels of homocysteine.[34, 
35]  Antioxidant compounds found in vegetables and wine may also play a protective role 
against cognitive decline, as oxidative damage may contribute to the development of AD and 
mild cognitive impairment.[36-38]  As an important source of omega-3 fatty acids, a 
component of neural membrane phospholipids, higher intake of fish may also be protective 
against cognitive decline.[39-41]  In their cross-sectional analysis of participants from the 
Washington Heights/Hamilton Heights Inwood Columbia Aging Project, Gu et al. found that, 
compared with those with high MedDiet adherence, participants with low MedDiet 
adherence had brain atrophy similar to that found after five years of aging, with higher fish 
intake and lower meat intake both being significantly associated with larger brain 
volumes.[19]   
Additionally, ARIC participants also consumed sweets and meats in quantities much 
greater than those recommended on the MedDiet pyramid.  In their analysis of dietary 
patterns among participants of the longitudinal Swedish National Study on Aging and Care – 
Kungsholmen (SNAC-K), Shakersain et al. found that a Western-style dietary pattern high in 
red and processed meats, refined grains, and sugars was associated with greater cognitive 
decline as measured by the MMSE.[6]  A case-control study of people with and without AD 
in Poland, in which researchers used factor analysis to derive the dietary patterns of people 
with AD and those without, found that the diets of people with AD were higher in meat and 
refined sugar while the diets of people without AD were higher in grains and vegetables.[42]  
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The low overall adherence to the MedDiet, with very low intakes of components that have 
been associated with less cognitive decline and high intakes of foods that have been 
associated with greater cognitive decline and incidence of AD found in the ARIC cohort may 
have contributed to the null results – this cohort may not have been consuming great enough 
amounts of MedDiet foods to show significant results.  
 This study has some significant limitations.  Though the 66-item semi-quantitative 
FFQ used in the ARIC study was validated, it was not designed to measure adherence to the 
Mediterranean Diet.  Specifically, the FFQ did not evaluate the use of olive oil, a major 
component of the MedDiet.  Sales of olive oil tripled between 1990 and 2012 in response to 
increasing public awareness of the possible health benefits associated with its use.[43]  It is 
likely that olive oil was not widely used among ARIC participants at the time of baseline 
examinations.  The FFQ also failed to distinguish between whole and refined grains on 
several food items, leaving the researchers to determine which food items were likely to be 
whole grains and which were likely to be refined based on knowledge of food products 
available at the time of data collection (“cooked cereals” and “dark or whole grain breads” 
were classified as whole grains, while “biscuits or cornbread,” “cold cereals,” and “white 
bread” were not).  Despite these limitations, this study is strengthened by the large sample 
size and the use of a MedDiet scoring system developed for non-Mediterranean populations.  
While many MedDiet scoring systems assign scores based the mean intake of each 
component found in the study population, meaning that participants with intakes higher than 
the population mean receive higher scores and those with intakes lower than the population 
mean receive lower scores, the MSDPS assigns scores based on the recommended intakes of 
each component from the Mediterranean Diet pyramid.  This allows for better evaluation of 
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true MedDiet adherence in populations where intakes of MedDiet components may be low.  
The MSDPS also accounts for overconsumption of each MedDiet component and the 
proportion of total calories from MedDiet components.  This attenuates the possibility of 
participants receiving a higher MedDiet score by simply consuming more food.[29] In a US 
population with traditionally low intake of MedDiet foods and higher intake of total energy, 
use of the MSDPS may be a better reflection of true MedDiet adherence than traditional 
scoring systems.  To our knowledge, this is the first study to use the MSDPS to analyze 
MedDiet adherence and cognitive decline.  The present study also uses a MedDiet score 
calculated from two food frequency questionnaires administered at baseline and visit 3 
(approximately six years after baseline).  Using the mean MedDiet score from baseline and 
visit 3 accounts for changes in the participants’ dietary patterns over time.   
 In conclusion, this observational study of a large diverse cohort of middle-aged adults 
found no significant associations between MedDiet adherence as measured by the MSDPS 
and rates of cognitive decline.  While these findings are inconsistent with many previous 
studies, this discrepancy may be explained by the novel approach to MedDiet scoring, which 
was designed for use in non-Mediterranean populations and bases scores on adherence to the 
traditional MedDiet pyramid rather than population means.  The very low MedDiet scores 
found using this scoring system may have contributed to the null results. 
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Tables 
Table 1.  Descriptive Statistics of ARIC Study Participants 
Variable Percent of Study Population 
Female 55.4% 
Black 18.5% 
Current Smoker 20.3% 
College Educated 39.3% 
Hypertensive 30.4% 
Diabetic 8.9% 
 Mean  SD 
Age (years) 54.0  5.7 
BMI (kg/m
2
) 27.4  5.1 
Physical Activity Score 7.1  1.4 
Average Mediterranean Diet Score 20.0  6.5 
Baseline Delayed Word Recall Score 6.7  1.5 
Baseline Digit Symbol Substitution Score 46.5  13.3 
Baseline Word Fluency Score 34.2  12.1 
Total Cognitive Change Score -0.6  1.9 
 
- DWR scores are out of maximum possible score of 10 
- DSS scores are out of a maximum possible score of 93 
- WF scores ranged from 0-99 
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Table 2.  Descriptive Statistics of Mediterranean Diet Sub-scores 
Variable Mean  SD 
Whole Grains 1.2  1.1 
Fruits 5.3  2.4 
Vegetables 2.5  1.4 
Dairy 4.7  2.3 
Wine 0.4  1.1 
Fish and other seafood 3.0  2.1 
Poultry 4.9  2.3 
Olives, legumes, and nuts 4.3  2.5 
Potatoes and other starchy roots 5.1  2.7 
Eggs 3.7  3.1 
Sweets 2.2  2.5 
Meat 2.4  2.8 
 
- Sub-scores are out of a maximum possible score of 10 
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Table 3.  Association of Mediterranean Diet Score and Cognitive Change 
Change in Cognition Scores Beta 95% Confidence Interval p Value 
Univariate Model -0.03 -0.09; 0.02 0.266 
Demographic Model -0.02 -0.08; 0.03 0.424 
Fully Adjusted Model 0.02 -0.04; 0.08 0.603 
 
- Univariate model compares average MedDiet score and change in cognitive scores 
- Demographic model includes sex, age, and ethnicity 
- Fully adjusted model includes education level, smoking status, physical activity level, BMI, 
hypertension, and diabetes 
- Beta represents the change in the difference between cognitive scores from visit 4 and visit 2 per 10 
point increase in MedDiet score 
 
  
 28 
Figures 
 
Figure 1.  Exclusion Flow Diagram 
 
 
 
Figure 2.  MSDPS Equation 
𝑀𝑆𝐷𝑃𝑆 =  [(
∑ 𝑆𝑖13𝑖=1
130
) ×  100] × 𝑃* 
*Where Si is the individual item score for each MedDiet component and P is the proportion of total energy 
intake from MedDiet foods 
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